Funds holding Kyverna Therapeutics Inc
ISIN US5019761049 · United States
- Fund holders
- 112
- Of which ETFs
- 23 89 other funds
- Value held
- 68.3M $
- Share of capital
- 12.8 % of 61.8M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 517 | 4.6K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 349 | 3.1K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 278 | 2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 267 | 1.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 226 | 2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 172 | 1.5K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 113 | 1K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 104 | 926.6 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 62 | 552.4 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 44 | 392 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 35 | 255.5 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 12 | 106.9 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 2.11 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 1.01 % | as of Jun 30, 2026 ↗ |
| WesMark Small Company Fund WesMark Funds | 0.53 % | as of Jun 30, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.34 % | as of May 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.17 % | as of Jun 30, 2026 ↗ |
| Federated Hermes Prudent Bear Fund Federated Hermes Equity Funds | 0.12 % | as of Jun 30, 2026 ↗ |
| Federated Hermes Managed Volatility Fund II Federated Hermes Insurance Series | 0.09 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.08 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 0.08 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Small Cap Equity Insights Fund Goldman Sachs Trust | 0.08 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 112 | +70 | 7,907,374 | +78.4 % |
| 2026Q2 | 42 | +5 | 4,432,095 | +5.4 % |
| 2026Q1 | 37 | +1 | 4,204,267 | +27.2 % |
| 2025Q4 | 36 | -20 | 3,305,188 | -17.0 % |
| 2025Q3 | 56 | -41 | 3,981,980 | -6.1 % |
| 2025Q2 | 97 | -5 | 4,241,231 | -23.3 % |
| 2025Q1 | 102 | +2 | 5,528,328 | +18.3 % |
| 2024Q4 | 100 | +37 | 4,673,250 | +13.4 % |
| 2024Q3 | 63 | -3 | 4,121,201 | +36.2 % |
| 2024Q2 | 66 | 3,026,876 |
Institutional managers
107 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GordonMD Global Investments LP | 4,244,818 | 36.6M $ | as of Mar 31, 2026 |
| GILEAD SCIENCES, INC. | 4,126,119 | 35.6M $ | as of Mar 31, 2026 |
| Bain Capital Life Sciences Investors, LLC | 3,110,000 | 26.8M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,000,000 | 17.3M $ | as of Mar 31, 2026 |
| AIGH Capital Management LLC | 2,000,000 | 17.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,555,287 | 13.4K $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,125,321 | 9.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,005,508 | 8.7M $ | as of Mar 31, 2026 |
| Insight Holdings Group, LLC | 989,054 | 8.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 977,289 | 8.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 877,078 | 7.6M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 845,325 | 7.3M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 721,581 | 6.2M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 644,421 | 5.6M $ | as of Mar 31, 2026 |
| MBB PUBLIC MARKETS I LLC | 614,477 | 5.3M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 605,512 | 5.2M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 577,600 | 5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | 4.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 449,750 | 3.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 423,826 | 3.7M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 412,032 | 3.6M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 367,492 | 3.2M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 333,692 | 2.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 222,929 | 1.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 212,910 | 1.8M $ | as of Mar 31, 2026 |
Declared shareholders of Kyverna Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BlackRock, Inc. | 5.10 % | 3,103,757 | as of Jun 30, 2026 · SCHEDULE 13G |
| Bain Capital Life Sciences Opportunities III, LP | 4.75 % | 2,885,000 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Kyverna Therapeutics Inc". https://titelia.com/en/stocks/kyverna-therapeutics-inc-US5019761049